Skip to main content
. 2018 Jun 25;20(11):2585–2597. doi: 10.1111/dom.13424

Figure 1.

Figure 1

Kaplan–Meier plots for on‐treatment comparisons of canagliflozin vs all non‐SGLT2i for HHF and BKLE amputation. Abbreviations: CCAE, Truven MarketScan Commercial Claims and Encounters; MDCD, Truven MarketScan Multi‐state Medicaid; MDCR, Truven MarketScan Medicare Supplemental Beneficiaries; ITT, intent‐to‐treat; BKLE, below‐knee lower extremity; HHF, hospitalization for heart failure